✦ LIBER ✦

Effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer patients with RRM1 low protein expression

✍ Scribed by Meiling Zhao; Haihong Yang; Jun liu; Yubao Guan; Mingchong Mo; Enyun Lin; Jianxing He

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Combination of low-dose cisplatin and ge

✍ J. Feliu; G. Martín; C. Madroñal; A. Rodríguez-Jaráiz; J. Castro; A Rodríguez; T 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB

A triplet chemotherapy with cisplatin, d

✍ Masahiro Tabata; Toshiyuki Kozuki; Hiroshi Ueoka; Katsuyuki Kiura; Shingo Harita 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 276 KB

Gene polymorphisms, pharmacokinetics, an

✍ M. Joerger; J. A. Burgers; P. Baas; V. D. Doodeman; P. H. M. Smits; R. S. Jansen 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 352 KB

Gemcitabine pharmacokinetics and interac

✍ Stacy S. Shord; Stephanie R. Faucette; Heidi H. Gillenwater; Scott L. Pescatore; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 275 KB

Clinical observation of docetaxel plus c

✍ Yongguang Cai; Ming Li; Xin Xie 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB